The reality is that we are still the only drug to
Post# of 148277
As for Nader to drop the patient count to 50 for interim … shows the need for quick results with 40 hospitals to run the trial for CD-16 is the priority now. Just as is the BTD for MTNBC. Severe can wait a little.
As for Severe Covid being delayed. I feel it’s more about focus on Critical than not having the cash to fund the Severe trial as some have suggested. Nader said we had 20 million left from last years authorized shares a week ago. So cash isn’t an issue if needed. I believe it is new focus to cross that finish line. Focus is on an EUA and fast. Maybe before years end.
As for Severe or for that matter Critical covid. Phizer is going for the Mild Covid. So what market will be left for us? Severe, Critical, and Long Haulers. The goal line crossing is close and is coming but you keep preaching your shit attitude and show everyone your pessimistic BS over and over. We all get tired of your little rants. If you want to make it personal we can do that.